Ophthalmology Activities
Highlighting Novel and Emerging Monoclonal Antibody Therapy for Neovascular Age Related Macular Degeneration and Diabetic Macular Edema
0290-0000-21-220-H01-P
This activity will present recent clinical data on approved agents, with a special focus on investigational anti-VEGF agents, delivery methods, and biosimilars in development.
1.50
Improving Visual Acuity and Patient Adherence in Neovascular Age-Related Macular Degeneration: A Review of Novel and Emerging Therapies for Specialty Pharmacists
0290-0000-21-207-H01-P
This activity will provide managed care and specialty pharmacists with an up-to-date review of currently available agents as well as the status of agents in development with the potential to expand the treatment landscape.
1.50
The Evolving Treatment Landscape for Neuromyelitis Optica Spectrum Disorder: Updates for Specialty and Infusion Pharmacists
0290-0000-21-218-H01-P
Examine the patient population afflicted with neuromyelitis optica spectrum disorder (NMOSD), including factors related to epidemiology, etiology, pathophysiology, clinical presentation, and diagnostic challenges
1.50
Clinical Management of Allergic Conjunctivitis: Integrating Recommendations to Improve Treatment Outcomes
0290-0000-21-067-H01-P
This activity features video vignettes that illustrate counseling interactions between a patient and a pharmacist to provide a clear understanding about recommending over-the-counter treatment options for patients.
2.00